Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://jaysonjddj047899.creacionblog.com/38858918/retaglutide-a-promising-glp-1-receptor-agonist